Most tumors include kidney cancer, liver cancer, brain, and central nervous system cancer, gastric cancer, bladder cancer, leukemia, colorectal cancer, ovarian cancer, head and neck cancer, lymphoma, esophageal cancer, breast cancer, sarcoma, pancreatic cancer, cervical cancer, lung cancer, prostate cancer, melanoma, and other cancer, had elevated C5orf34 levels than normal tissues, according to Oncomine data. This evidence concerns the gene C5orf34 and prostate carcinoma.